CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 13 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 559,900 | $2,111,000 | 0.75% |
| WEDBUSH SECURITIES INC | 13,900 | $52,000 | 0.01% |
| MinichMacGregor Wealth Management, LLC | 800 | $3,000 | 0.00% |
| UBS Group AG | 180 | $1,000 | 0.00% |
| D'Orazio & Associates, Inc. | 100 | $0 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 30,913 | $117,000 | 0.00% |
| Parallel Advisors, LLC | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 21,692 | $82,000 | 0.00% |
| DEUTSCHE BANK AG\ | 2,403 | $9,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 10,346 | $39,000 | 0.00% |